elliot Servais to Databases, Factual
This is a "connection" page, showing publications elliot Servais has written about Databases, Factual.
Connection Strength
1.161
-
Servais EL, Towe CW, Brown LM, Broderick SR, Block MI, Burfeind WR, Mitchell JD, Schipper PH, Raymond DP, David EA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2020 Update on Outcomes and Research. Ann Thorac Surg. 2020 09; 110(3):768-775.
Score: 0.539
-
Watkins AA, Rizvi TZ, Lopez E, Shehata D, Ssemaganda H, Lin Z, Stock CT, Moffatt-Bruce SD, Servais EL. Trends and comparative outcomes between operative approaches for segmentectomy in lung cancer. J Thorac Cardiovasc Surg. 2025 Mar; 169(3):745-752.e2.
Score: 0.179
-
Servais EL, Blasberg JD, Brown LM, Towe CW, Seder CW, Onaitis MW, Block MI, David EA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2022 Update on Outcomes and Research. Ann Thorac Surg. 2023 01; 115(1):43-49.
Score: 0.159
-
Servais EL, Towe CW, Farjah F, Brown LM, Broderick SR, Block MI, Burfeind WR, Mitchell JD, Schipper PH, Raymond DP, David EA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2021 Update on Outcomes and Research. Ann Thorac Surg. 2021 09; 112(3):693-700.
Score: 0.145
-
Blasberg JD, Servais E, Thibault D, Jacobs JP, Kozower B, David E, Donahue J, Vekstein A, Kang L, Hartwig M, Jones LA, Kosinski A, Habib R, Towe C, Seder CW. Longitudinal Follow-up of Medicare Patients After Esophageal Cancer Resection in the STS Database. Ann Thorac Surg. 2025 Feb; 119(2):333-342.
Score: 0.045
-
Towe CW, Servais EL, Brown LM, Blasberg JD, Mitchell JD, Worrell SG, Seder CW, David EA. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2023 Update on Outcomes and Research. Ann Thorac Surg. 2024 03; 117(3):489-496.
Score: 0.043
-
Yambayev I, Sullivan TB, Suzuki K, Zhao Q, Higgins SE, Yilmaz OH, Litle VR, Moreira P, Servais EL, Stock CT, Quadri SM, Williamson C, Rieger-Christ KM, Burks EJ. Pulmonary Adenocarcinomas of Low Malignant Potential: Proposed Criteria to Expand the Spectrum Beyond Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma. Am J Surg Pathol. 2021 04 01; 45(4):567-576.
Score: 0.036
-
Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LK, Wong WD, Paty PB. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009 Jul 10; 27(20):3379-84.
Score: 0.016